Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31569170 | 1.00 | PDK1 (0.33) | PDK1PDK2 | |
| SCHEMBL31569454 | 1.00 | PDK1 (0.33) | PDK1PDK2 | |
| Hydrochloric Acid SCHEMBL34469191 | 0.80 | — | — | |
| SCHEMBL5232115 | 0.71 | DPP4 (0.33) | — | |
| SCHEMBL31177343 | 0.71 | DPP4 (0.33) | — | |
| SCHEMBL31568988 | 0.69 | — | — | |
| SCHEMBL31568966 | 0.68 | PDK1 (0.33) | PDK1PDK2 | |
| SCHEMBL31569146 | 0.67 | HTR2A (0.33) | PDK1PDK2 | |
| Hydrochloric Acid SCHEMBL16145625 | 0.65 | TACR3 (0.32) | — | |
| SCHEMBL24711537 | 0.62 | PDK2 (0.33) | PDK1PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115174-A1 | PHARMACOLOGICAL CORRECTORS OF RHODOPSIN AND USES THEREOF | OCTANT INC (US) | 2026-04-30 | — | — | US | disclosed |
| WO-2025101780-A1 | PHARMACOLOGICAL CORRECTORS OF RHODOPSIN AND USES THEREOF | OCTANT, INC. (US) | 2025-05-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115174-A1 | PHARMACOLOGICAL CORRECTORS OF RHODOPSIN AND USES THEREOF | PDE6D, PDE6H, ADRA1D | PDK1 4522/4885PDK2 4793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.